TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Oct 19, 2026 · Director, CHIEF EXECUTIVE OFFICER Dube Eric M sold 243.74K shares at $53.82/share ($13.1M); exercised options for 487.47K shares

Director, CHIEF EXECUTIVE OFFICER Dube Eric M sold 243.74K shares at $53.82/share ($13.1M); exercised options for 487.47K shares

xslF345X06/form4-10192026_041001.xml

xslF345X06/form4-10192026_041001.xmlSEC.gov

Graphics and non-inline formats (not embedded below).